• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原球蛋白通过增加 Smad1/5 的激活并抑制 SK-Hep1 肝癌细胞中的 Smad2/3 信号通路,抑制转化生长因子-β诱导的上皮间质转化。

Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

机构信息

Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Bio-MAX institute, Seoul National University, Seoul, Korea.

出版信息

PLoS One. 2022 May 17;17(5):e0266409. doi: 10.1371/journal.pone.0266409. eCollection 2022.

DOI:10.1371/journal.pone.0266409
PMID:35580109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9113573/
Abstract

Transforming growth factor-β (TGF-β) is an important inducer of the epithelial-to-mesenchymal transition (EMT) in various cancers. Our previous study demonstrated that prohaptoglobin (proHp) stimulates Smad1/5 activation via ALK1, a TGF-β type I receptor, in endothelial cells, suggesting that proHp plays a role in TGF-β signaling. However, the function of proHp in cellular events downstream of Smads remains unclear. The current study investigated the effects of proHp on TGF-β-mediated Smad-dependent EMT induction and cell invasion in vitro using proHp-overexpressing SK-Hep1 liver cancer cells. The results of Western blotting, quantitative real-time RT-PCR, and immunocytochemistry indicated that proHp downregulated expression of mesenchymal marker and EMT regulator such as N-cadherin, vimentin, and twist, and upregulated expression of the epithelial marker E-cadherin. Compared with control cells, proHp-overexpressing cells exhibited high levels of ALK1/2/3 receptors and markedly increased Smad1/5 phosphorylation. Interestingly, proHp attenuated TGF-β-induced expression of mesenchymal markers and Smad2/3 phosphorylation. It also significantly suppressed cell invasion and migration. Knockdown of Smad1/5 abolished the inhibitory effects of proHp on TGF-β-stimulated Smad2/3 phosphorylation and mesenchymal marker expression. These findings indicate that proHp suppresses the TGF-β-induced EMT and cell invasion in vitro by enhancing Smad1/5 activation via ALK1/2/3 receptors and thus suppressing the Smad2/3 signaling pathway in SK-Hep1 cells. This study suggests that proHp may prevent a de-differentiation of hepatic cells and induce a cell differentiation by regulating the Smad signaling pathway.

摘要

转化生长因子-β(TGF-β)是各种癌症中上皮间质转化(EMT)的重要诱导因子。我们之前的研究表明,前血影蛋白(proHp)通过 TGF-β Ⅰ型受体 ALK1 刺激 Smad1/5 的激活,提示 proHp 在 TGF-β信号转导中发挥作用。然而,proHp 在 Smads 下游细胞事件中的功能尚不清楚。本研究通过过表达前血影蛋白的 SK-Hep1 肝癌细胞,在体外研究了前血影蛋白对 TGF-β 介导的 Smad 依赖性 EMT 诱导和细胞侵袭的影响。Western blot、定量实时 RT-PCR 和免疫细胞化学结果表明,前血影蛋白下调了间质标志物和 EMT 调节剂如 N-钙粘蛋白、波形蛋白和 twist 的表达,而上调了上皮标志物 E-钙粘蛋白的表达。与对照细胞相比,过表达前血影蛋白的细胞表现出高水平的 ALK1/2/3 受体,并且 Smad1/5 磷酸化明显增加。有趣的是,前血影蛋白减弱了 TGF-β 诱导的间质标志物表达和 Smad2/3 磷酸化。它还显著抑制了细胞侵袭和迁移。Smad1/5 的敲低消除了前血影蛋白对 TGF-β 刺激的 Smad2/3 磷酸化和间质标志物表达的抑制作用。这些发现表明,前血影蛋白通过增强 ALK1/2/3 受体的 Smad1/5 激活,抑制 SK-Hep1 细胞中的 Smad2/3 信号通路,从而抑制 TGF-β 诱导的 EMT 和细胞侵袭。本研究提示,前血影蛋白可能通过调节 Smad 信号通路来防止肝实质细胞去分化并诱导细胞分化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/bd6f27afed54/pone.0266409.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/cf2883fa872d/pone.0266409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/6b192fe345a0/pone.0266409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/193555509d7b/pone.0266409.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/eb354c37c14d/pone.0266409.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/d6a7b759f582/pone.0266409.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/bd6f27afed54/pone.0266409.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/cf2883fa872d/pone.0266409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/6b192fe345a0/pone.0266409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/193555509d7b/pone.0266409.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/eb354c37c14d/pone.0266409.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/d6a7b759f582/pone.0266409.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf3/9113573/bd6f27afed54/pone.0266409.g006.jpg

相似文献

1
Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.原球蛋白通过增加 Smad1/5 的激活并抑制 SK-Hep1 肝癌细胞中的 Smad2/3 信号通路,抑制转化生长因子-β诱导的上皮间质转化。
PLoS One. 2022 May 17;17(5):e0266409. doi: 10.1371/journal.pone.0266409. eCollection 2022.
2
Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis.通过 TGF-β1-ALK1-Smad1/5 信号转导上调胎盘生长因子参与原结合珠蛋白诱导的血管生成。
PLoS One. 2019 Apr 29;14(4):e0216289. doi: 10.1371/journal.pone.0216289. eCollection 2019.
3
Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFR Regulating TGF-/Smad Pathway.小檗碱通过与 TGF-β/Smad 通路调节的 TGR 联合抑制肝和胃癌细胞中的 EMT。
Oxid Med Cell Longev. 2021 Oct 18;2021:2337818. doi: 10.1155/2021/2337818. eCollection 2021.
4
Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.转化生长因子-β通过激活素受体样激酶1刺激新生小鼠肺动脉平滑肌细胞和成纤维细胞中的Smad1/5信号通路。
Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L615-L627. doi: 10.1152/ajplung.00079.2017. Epub 2017 Jun 22.
5
TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition.TGF-β 通过一种新颖的受体激活方式磷酸化 SMAD1/5,诱导上皮间质转化。
Elife. 2018 Jan 29;7:e31756. doi: 10.7554/eLife.31756.
6
Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.转化生长因子-β1通过抑制Smad1/5/9信号通路抑制骨形态发生蛋白-2诱导的HSC-4人口腔鳞状细胞癌细胞间充质-上皮转化。
Oncol Rep. 2017 Feb;37(2):713-720. doi: 10.3892/or.2016.5338. Epub 2016 Dec 28.
7
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.胶质母细胞瘤中SMAD2/3与SMAD1/5/8信号通路对转化生长因子-β诱导的、ALK-5介导的血管内皮生长因子释放的差异调节
Neuro Oncol. 2015 Feb;17(2):254-65. doi: 10.1093/neuonc/nou218. Epub 2014 Aug 27.
8
Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.Smad2/3/4信号通路通过靶向Timp3促进TGF-β诱导的miRNA-181b表达,从而推动胃癌转移。
Cell Physiol Biochem. 2016;39(2):453-66. doi: 10.1159/000445638. Epub 2016 Jul 7.
9
Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.转化生长因子β诱导的上皮细胞中Smad1/5磷酸化由新型受体复合物介导,且对不依赖贴壁生长至关重要。
Mol Cell Biol. 2008 Nov;28(22):6889-902. doi: 10.1128/MCB.01192-08. Epub 2008 Sep 15.
10
[Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].[上皮-间质转化中TGF-β信号通路的异常激活机制]
Yakugaku Zasshi. 2021;141(11):1229-1234. doi: 10.1248/yakushi.21-00143.

引用本文的文献

1
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer.Notch3介导的TGF-β1激活增强非小细胞肺癌中的上皮-间质转化和癌症干性。
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5791. Epub 2025 Aug 24.
2
MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid.MeCP2 功能障碍可阻止脑类器官中 BMP 信号的正常传递和神经祖细胞的扩增。
Ann Clin Transl Neurol. 2023 Jul;10(7):1170-1185. doi: 10.1002/acn3.51799. Epub 2023 Jun 11.

本文引用的文献

1
Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers.评估触珠蛋白及其蛋白形式作为胶质母细胞瘤标志物。
Int J Mol Sci. 2021 Jun 18;22(12):6533. doi: 10.3390/ijms22126533.
2
[Haptoglobin as a biomarker].[触珠蛋白作为一种生物标志物]
Biomed Khim. 2021 Mar;67(2):105-118. doi: 10.18097/PBMC20216702105.
3
Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism.鉴定胰腺癌组织中岩藻糖化触珠蛋白产生细胞及其分子机制。
Glycoconj J. 2021 Feb;38(1):45-54. doi: 10.1007/s10719-020-09970-8. Epub 2021 Feb 1.
4
Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications.肝细胞癌的去分化:分子机制及治疗意义
Am J Transl Res. 2020 May 15;12(5):2099-2109. eCollection 2020.
5
Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis.通过 TGF-β1-ALK1-Smad1/5 信号转导上调胎盘生长因子参与原结合珠蛋白诱导的血管生成。
PLoS One. 2019 Apr 29;14(4):e0216289. doi: 10.1371/journal.pone.0216289. eCollection 2019.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.癌相关触珠蛋白特异性抗体的建立:临床研究的一种可能启示。
Oncotarget. 2018 Jan 29;9(16):12732-12744. doi: 10.18632/oncotarget.24332. eCollection 2018 Feb 27.
8
TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition.TGF-β 通过一种新颖的受体激活方式磷酸化 SMAD1/5,诱导上皮间质转化。
Elife. 2018 Jan 29;7:e31756. doi: 10.7554/eLife.31756.
9
FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.FAD104 是脂肪生成的调节剂,是一种新型的 TGF-β 介导的 EMT 抑制因子,在宫颈癌细胞中。
Sci Rep. 2017 Nov 27;7(1):16365. doi: 10.1038/s41598-017-16555-3.
10
Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.转化生长因子-β通过激活素受体样激酶1刺激新生小鼠肺动脉平滑肌细胞和成纤维细胞中的Smad1/5信号通路。
Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L615-L627. doi: 10.1152/ajplung.00079.2017. Epub 2017 Jun 22.